Characteristic | Endovascular treatment group Mean±SD (n=67) [Median] (IQR) | Control group Mean±SD (n=64*) [Median] (IQR) | P value |
Age (years) | 66.0±13.7 (67) [66.4] (56.9,76.0) | 65.2±12.0 (64) [65.9] (57.9,75.0) | 0.71 |
Sex (female, %) | 53.7% (36/67) | 46.9% (30/64) | 0.49 |
History of hypertension (%) | 61.2% (41/67) | 59.4% (38/64) | 0.86 |
History of dyslipidemia (%) | 36.9% (24/65) | 35.9% (23/64) | 1.00 |
History of diabetes mellitus (%) | 16.4% (11/67) | 21.9% (14/64) | 0.51 |
Atrial fibrillation (%) | 38.1% (24/63) | 28.3% (17/60) | 0.34 |
NIHSS at baseline | 14.4±5.1 (67) [14.0] (11.0,19.0) | 15.4±6.0 (63) [15.0] (11.0,20.0) | 0.32 |
Baseline non-contrast CT ASPECTS | 8.6±1.4 (67) [9.0] (8.0,10.0) | 8.1±1.6 (64) [8.0] (7.0,10.0) | 0.06 |
Intravenous alteplase administered | 85.1% (57/67) | 89.1% (57/64) | 0.61 |
Stroke onset to intravenous alteplase bolus (min) | 119.6±54.3 (56) [107.5] (83.8,136.3) | 113.5±44.8 (57) [100.0] (84.0,140.0) | 0.52 |
Stroke onset to randomization (min) | 199.5±84.1 (67) [180.0] (147.5,250.5) | 209.0±76.5 (63) [193.0] (152.5,264.0) | 0.50 |
Stroke onset to groin puncture (min) | 238.2±90.3 (61) [220.0] (90.0,599.0) | – | – |
*One patient with missing 90-day outcome was excluded from the outcome analysis.
ASPECTS, Alberta Stroke Programme Early CT Score; NIHSS, National Institute of Health Stroke Score.